19815 Bay Branch Rd
Andalusia, Alabama 36420
(334) 222-2523
HELPLINE: 1-877-530-0002



Facebook    

 

SCAMHC is an approved Mental Health site for the National Health Service Corps Loan Repayment program.  Find out the program details and see if you qualify by visiting: http://nhsc.hrsa.gov/

SCAMHC is an Equal Opportunity Provider and Employer and maintains a Drug-Free Workplace

 

 

 

 


powered by centersite dot net
Medications
Resources
Basic InformationLatest News
COVID Drug Remdesivir Could Cost Up to $3,120 Per Patient, Maker SaysHigh Costs Lead Millions of Americans to Shop Abroad for Rx DrugsFDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19How Ritalin Works in the BrainFDA Pulls Heartburn Drug Zantac From MarketTaking More Antibiotics May Up Odds for HospitalizationAllergy Med Singulair to Get 'Black Box' Warning Over Psych Side Effects: FDAU.S. Drug Prices Have Risen Three Times Faster Than InflationUse Pot? It Can Interact With Your Meds in Harmful WaysToo Many Antibiotics, Opioids Given to Dental Patients in the ERBrand-Name Rx Rise After Docs Get Drug Company Perks: StudyAs Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go WithoutPrice Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersAI May Help Guide Patients to Most Effective Antidepressant1 in 4 Gets Unneeded Antibiotics at Children's HospitalsStudy Finds 'No Clear Rationale' for 45% of Antibiotic PrescriptionsAre Antibiotics a Recipe for Obesity in Childhood?Do You Take Warfarin? Time of Day Might Not MatterNew Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?Health Tip: Acetaminophen SafetyTwo More Heartburn Meds Recalled Due to Possible CarcinogenMany Drugstores Misinform on Disposal of Unused MedsHealth Tip: How to Remember to Take Your MedicationsFDA to Allow States to Import Prescription Drugs From Other CountriesOver 40% of Antibiotics Could Be 'Inappropriately' PrescribedFDA Testing Levels of Carcinogen in Diabetes Drug MetforminTaking Several Prescription Drugs May Trigger Serious Side EffectsPenicillin Allergy Less Common Than Thought: StudyMany Older Americans Misuse Antibiotics: PollAntibiotics Not Recommended for Most Toothaches, New Guideline SaysHealth Tip: Taking Anti-Inflammatory DrugsMany Common Meds Could Alter Your MicrobiomeWhen Meds Are Free, Patients Take Them More OftenMaker Halts Distribution of Generic Zantac Due to Possible CarcinogenKids Often Prescribed Drugs 'Off-Label,' Raising ConcernsHeartburn Drug Zantac May Contain Small Amounts of Known Carcinogen, FDA SaysHealth Tip: Take Over-the-Counter Medication WiselyA Prescription for Medicating Your Child SafelyHealth Tip: Taking Dietary SupplementsTrump Administration Announces Plan to Allow Cheaper Drug Imports From CanadaAre Too Many Kids Prescribed Antihistamines?Some Meds and Driving a Dangerous DuoHealth Tip: Giving Medicine Safely to ChildrenHigher Cost of New Cholesterol Drugs Putting Patients at Risk: StudyMany Americans Take Antibiotics Without a PrescriptionHealth Tip: Packing Prescriptions for Travel
Questions and AnswersVideosLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Depression & Related Conditions
Mental Disorders
Mental Health Professions

Brand-Name Rx Rise After Docs Get Drug Company Perks: Study

HealthDay News
by -- Robert Preidt
Updated: Feb 21st 2020

new article illustration

FRIDAY, Feb. 21, 2020 (HealthDay News) -- American doctors prescribe more brand-name medications after they get a free lunch or other incentives from drug company marketers, a new study finds.

Researchers analyzed drug prescribing between 2013 and 2015 for a large sample of enrollees in Medicare Part D. The federal program, which subsidizes prescriptions for 37 million seniors and disabled people, accounts for nearly one-third of U.S. retail prescription drug sales.

That data was compared with a database in which drug companies report incentives provided to doctors, including meals, travel or continuing education expenses.

While those incentives tended to be modest -- 95% were meals, of which 80% were valued at less than $20 -- they were common and had an impact, according to the study.

More than 20% of Medicare Part D expenses on brand-name medications came from doctors who received an incentive related to a drug they prescribed. Nearly 30% of physicians got an incentive for at least one drug they prescribed during the study period.

"The prevalence of the practice implies that the financial impacts are economically large," the authors wrote in the working paper released Feb. 17 by the National Bureau of Economic Research.

Colleen Carey, an assistant professor of policy analysis and management at Cornell University, is the study's first author.

She and her colleagues estimated that for every additional dollar that drug companies spent on marketing visits, they could expect $2.64 more in drug revenue over the next year. That's a 164% return on investment.

That wasn't as high as previous estimates, which ranged from 200% to 1,700%, the researchers noted.

They also found that marketing visits by drug company reps don't lead doctors to prescribe higher-quality drugs, as the drug industry claims.

"We took seriously the claim that there is educational value to these marketing encounters," Carey said in a Cornell news release. "We just don't find any evidence for it."

More information

Santa Clara University has more on drug company gifts to doctors.